|Articles|January 1, 2019
- Pharmaceutical Executive-01-01-2019
- Volume 39
- Issue 1
Pharmaceutical Executive, January 2019 Issue (PDF)
Click the title above to open the Pharmaceutical January 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Ipsen’s David Meek: Tasked to Transformover 7 years ago
Drug Research and Review Issues on Radar at FDAover 7 years ago
Finding the Right Digital Health Partnerover 7 years ago
Future Pharma: Data Science as a Strategic Partnerover 7 years ago
Ascending the Uncanny Valley in Healthcareover 7 years ago
Country Report: TurkeyAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5